S095029
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for S095029, covering 2026-03-13 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers. [Phase 1, Phase 2]